WELL — Welltower Inc.
Fundamentals Score: 68.1/100 (Good Fundamentals) · Real Estate
Welltower Inc. (NYSE:WELL), an S&P 500 company based in Toledo, Ohio, is a leader in reshaping healthcare infrastructure. This Real Estate Investment Trust (REIT) strategically collaborates with premier operators in seniors housing, post-acute care, and health systems.
Score Breakdown
Live Market DataPrice updated: 4h ago
AI Deep-Dive Analysis
Analysis as of 2026-08-27 - price/technical figures below reflect that date, not live market dataAs of 2026-08-27, Welltower traded at $239.53, down 0.84% on the day, near the high end of its 52-week range with a market cap of $172.6B. Q2 2026 revenue beat, 2026 FFO guidance was raised, and the analyst consensus is Buy with a ~$255 average price target.
Market sentiment is bullish: Q2 2026 revenue grew 39.1% YoY to $3.54B versus the $3.36B consensus, management raised 2026 normalized FFO guidance to $6.36-$6.44, same-store NOI accelerated to 8.5%, the dividend was raised 15% to $0.85 per quarter, and a director bought roughly $2.4M of stock in late August. The main blemish was normalized EPS of $0.61 versus $0.66 consensus, but the raised FFO guidance and 25 of 35 analysts at Buy/Strong Buy with zero Sells dominate the narrative.
This is an accelerating trend, not a one-quarter blip. Quarterly revenue has climbed from $1.63B in Q3 2023 to $3.54B in Q2 2026, with YoY growth accelerating to roughly 39%. GAAP operating income is noisy - Q4 2025 printed -$944M, likely driven by impairments/non-cash charges - but underlying cash flow is strong: Q2 2026 operating cash flow hit $1.20B versus $770M a year earlier. Same-store NOI growth of 8.5%, with Seniors Housing Operating SSNOI guided to 18.5%-21.5%, confirms the inflection is structural, supported by demographics and pricing power.
Expensive on conventional metrics. As of 2026-08-27, TTM P/E is 124.1x, forward P/E on next-fiscal-year EPS consensus of $2.79 is roughly 85.7x, and price-to-sales is 13.7x versus Welltower's own 5-year average of 8.3x. The more relevant REIT metric is forward P/FFO: at the $6.40 midpoint of 2026 normalized FFO guidance, shares trade around 37.4x forward FFO. That is a rich multiple, though the froth is partially justified by 20%+ FFO growth, 8.5% same-store NOI growth, and an investment-grade balance sheet.
The market is not paying for trailing GAAP EPS of $1.91; it is paying for normalized FFO and the growth runway. At $239.53, the stock is capitalizing 2026 midpoint FFO at roughly 37.4x, which only makes sense if FFO keeps compounding at a double-digit clip and the >$10B acquisition pipeline closes accretively. If management merely hits guidance, the stock is roughly fully valued; if guidance is raised again or rate relief arrives, there is upside toward analyst targets; if occupancy or rent growth stalls, the high multiple leaves limited downside cushion.
As of 2026-08-27, RSI was 55.4, so momentum was neither overbought nor oversold. Price was 1.6% above the 20-day SMA, 2.3% above the 50-day SMA, and 14.3% above the 200-day SMA. The chart is in a solid uptrend after a strong run toward the 52-week high of $255.20. Entry timing is the issue: chasing here is less attractive than waiting for a pullback toward the $235-237 support zone around the 20/50-day moving averages.
- Interest rates: persistent Treasury yield volatility and higher financing costs are a headwind for capital-intensive REITs, though Welltower's 0.43 debt-to-equity and investment-grade ratings provide cushion.
- Demographics: the 'silver tsunami' is driving structural demand for senior housing across the US, UK, and Canada.
- Acquisition pricing: elevated asset values make the >$10B deployment pipeline a potential source of value creation only if purchases close at sufficiently accretive yields.
- Labor and operating costs: staffing pressure in seniors housing could compress margins if occupancy and rent growth cool from current levels.
- REIT sector rotation: with the stock near valuation highs, any shift in risk appetite or relative yield spreads can produce sharp multiple compression.
- Q3 2026 earnings, typically late October/early November, with focus on SHO occupancy and whether same-store NOI guidance is raised again.
- Capital deployment updates on the >$10B acquisition pipeline; accretive closings would push forward FFO estimates higher.
- A more favorable rate environment or falling Treasury yields, which would likely spark REIT multiple expansion.
- Further analyst price target increases following Q2; KeyBanc and Citi recently moved to $275.
- Valuation risk: ~37x forward FFO and 13.7x sales leave little room for growth disappointment.
- Rising long-term interest rates: higher yields typically compress REIT multiples and raise the cost of future acquisitions.
- Execution/integration risk on the acquisition pipeline and the Welltower Business System rollout.
- Operational deceleration: if senior-housing occupancy growth and SSNOI momentum fade, the premium multiple will look unjustified.
Welltower is a high-quality senior-housing REIT with a powerful demographic tailwind, accelerating same-store NOI, strong cash flow, and a well-managed balance sheet. The issue is price: at $239.53, the stock is fully valuing strong execution, so the risk/reward favors owning on a pullback rather than chasing strength. The business is excellent; the margin of safety is not.
I applied a 37.5x multiple to the $6.40 midpoint of 2026 normalized FFO guidance - a premium multiple justified by ~20% FFO growth and 8.5% same-store NOI growth, but not multiple expansion above today's implied level - yielding a fair value of $240.00. This is my own estimate, distinct from the ~$255 consensus price target, and implies the stock is roughly fairly valued as of 2026-08-27.
AI Review of the Deterministic Score
The deterministic score of 68.1 and 'Good Fundamentals' band are in the right neighborhood, and I would not call this a weak business. However, the fixed formula's quality/profitability leg understates Welltower because REIT GAAP accounting - depreciation plus the Q4 2025 operating income swing to -$944M - depresses operating margin and ROIC. Cash flow quality is actually healthy, with a negative accruals ratio of -1.37%, and the research brief shows accelerating FFO guidance, record SSNOI, and a dividend hike. I would push the overall score into the mid-70s, roughly 10 points higher, which keeps it in 'Good Fundamentals' territory but justifies a Partially Agree rather than a full endorsement.
AI-generated analysis for informational purposes only, not financial advice.